The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism
Authors:
Open Access
- 28 August 2015
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , srep13528
Abstract
Prostate cancer at advanced stages including metastatic and castration-resistant cancer remains incurable due to the lack of effective therapies. MiR-190a belongs to the small noncoding RNA family and has an important role in breast cancer metastasis. However, it is still unknown whether miR-190a plays a role in prostate cancer development. Herein, we first observed AR/miR-190a/YB-1 forms an auto-regulatory negative feedback loop in prostate cancer: miR-190a expression was down-regulated by AR activation; YB-1 functions are as an AR activator; miR-190a inhibited AR expression and transactivation through direct binding to 3′UTR of YB-1 gene. MiR-190a contributes the human prostate cancer cell growth through AR-dependent signaling. Moreover, we examined the expression of miR-190a and observed a significant decrease in human prostate cancers. Reduced expression of miR-190a was inversely correlated to AR levels of prostate cancer patients, and patients with higher miR-190a expression in their tumor have improved tumor-free survival. Taken together, our findings identified a biochemical and functional link between miR-190a with reduced expression in advanced prostate cancer, YB-1 and AR signaling in prostate cancer.Keywords
This publication has 38 references indexed in Scilit:
- Androgen receptor co-regulatory networks in castration-resistant prostate cancerEndocrine-Related Cancer, 2013
- A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasisHuman Molecular Genetics, 2013
- Transcriptional changes induced by the tumor dormancy-associated microRNA-190Transcription, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- MicroRNAs and Prostate CancerThe Cancer Journal, 2012
- Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expressionEndocrine-Related Cancer, 2011
- MicroRNAs and prostate cancerEndocrine-Related Cancer, 2010
- Progression of prostate cancer: Multiple pathways to androgen independenceCancer Letters, 2009
- Mechanisms of the development of androgen independence in prostate cancerWorld Journal of Urology, 2005
- Androgen Receptor in Prostate CancerEndocrine Reviews, 2004